BCTX
Briacell Therapeutics
BCTX
BCTX
20 hedge funds and large institutions have $452K invested in Briacell Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
93% less capital invested
Capital invested by funds: $6.38M → $452K (-$5.93M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
20
Holding in Top 10
–
Calls
$137K
Puts
$31K
Top Buyers
| 1 | +$14.1K | |
| 2 | +$13.2K | |
| 3 | +$12.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.61K |
| 5 |
Renaissance Technologies
New York
|
+$3.25K |
Top Sellers
| 1 | -$249K | |
| 2 | -$99.5K | |
| 3 | -$97.9K | |
| 4 |
Morgan Stanley
New York
|
-$23.6K |
| 5 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$20.2K |